hydroxychloroquine (Z0188)
EFC12368
Phase 3 small_molecule completed
Quick answer
hydroxychloroquine (Z0188) for Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus is a Phase 3 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed